Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001640334-25-001839
Filing Date
2025-10-14
Accepted
2025-10-14 16:01:36
Documents
91

Document Format Files

Seq Description Document Type Size
1 FORM S-1 lxrp_s1.htm   iXBRL S-1 2423859
2 OPINION lxrp_ex51.htm EX-5.1 6806
3 CONSENT lxrp_ex231.htm EX-23.1 1937
4 FILING FEE lxrp_ex107.htm   iXBRL EX-FILING FEES 37519
10 lxrp_s1img4.jpg GRAPHIC 14690
11 lxrp_s1img3.jpg GRAPHIC 14690
12 lxrp_ex51img1.jpg GRAPHIC 7046
  Complete submission text file 0001640334-25-001839.txt   9581814

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA lxrp-20250531.xsd EX-101.SCH 77892
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE lxrp-20250531_lab.xml EX-101.LAB 418044
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lxrp-20250531_cal.xml EX-101.CAL 52069
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lxrp-20250531_pre.xml EX-101.PRE 354605
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lxrp-20250531_def.xml EX-101.DEF 198409
94 EXTRACTED XBRL INSTANCE DOCUMENT lxrp_s1_htm.xml XML 1826212
95 EXTRACTED XBRL INSTANCE DOCUMENT lxrp_ex107_htm.xml XML 6791
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: S-1 | Act: 33 | File No.: 333-290862 | Film No.: 251391697
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)